Evaluation of clinical pharmacist interventions on drugrelated problems in the gastroenterology ward

Basit Öğe Kaydı
dc.authorid0000-0002-2018-9619
dc.contributor.authorCeylan, Cengizhan
dc.contributor.authorSancar, Mesut
dc.contributor.authorBeceren, Ayfer
dc.contributor.authorDemir, Ali
dc.contributor.authorKuş, Coşkun
dc.contributor.authorOmurtag, Gülden Zehra
dc.date.accessioned2022-10-07T08:34:41Z
dc.date.available2022-10-07T08:34:41Z
dc.date.issued2022
dc.departmentİstanbul Medipol Üniversitesi, Eczacılık Fakültesi, Eczacılık Meslek Bilimleri Bölümü, Farmasötik Toksikoloji Ana Bilim Dalı
dc.description.abstractIntegrating clinical pharmacists in a multidisciplinary patient care team improves the treatment process by identifying and resolving drug-related problems (DRPs). The aim of the study was to determine the effect of clinical pharmacist intervention for DRPs in the gastroenterology service. The first period of the study was conducted between 15.06.2018 and 15.02.2019. Eighty patients admitted to the gastroenterology ward, who used at least one medication, were included in ‘the study group’. The clinical pharmacist participated in ward rounds and made interventions to solve identified DRPs. In the second period of the study, the control group consisted of 80 patients admitted to the same ward between 01.03.2019 and 06.06.2019. DRPs were determined only from the data obtained from the hospital system in the control group. DRPs were classified according to the European Pharmaceutical Care Network (PCNE V9.1). A total of 136 and 46 with an average of 1.7 and 0.57 DRPs per patient (p?0.01) were identified in the study and control groups, respectively. Of the DRPs in the study group, 59 were related to treatment effectiveness, while 61 were related to treatment safety. Likewise, 21 DRPs were related to treatment effectiveness in the control group, while 12 were related to treatment (p?0.01). 65% of the interventions were made at the physician level and 49% at the drug level. 97% (n=133) of the total interventions were accepted. The number of DRPs was significantly reduced in the control group within the time frame after the clinical pharmacist intervention period. In conclusion, clinical pharmacists' importance in detecting and preventing DRPs in the gastroenterology ward has been demonstrated.
dc.identifier.citationCeylan, C., Sancar, M., Beceren, A., Demir, A., Kuş, C. ve Omurtag, G. Z. (2022). Evaluation of clinical pharmacist interventions on drugrelated problems in the gastroenterology ward. Journal of Research in Pharmacy (Online), 26(3), 669-678. https://doi.org/10.29228/jrp.166
dc.identifier.doi10.29228/jrp.166
dc.identifier.endpage678
dc.identifier.issn2630-6344
dc.identifier.issue3
dc.identifier.startpage669
dc.identifier.trdizinid515839
dc.identifier.urihttps://doi.org/10.29228/jrp.166
dc.identifier.urihttps://hdl.handle.net/20.500.12511/9807
dc.identifier.volume26
dc.indekslendigikaynakTR-Dizin
dc.institutionauthorOmurtag, Gülden Zehra
dc.language.isoen
dc.publisherMarmara University
dc.relation.ispartofJournal of Research in Pharmacy (Online)en_US
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectGastroenterology Ward
dc.subjectDrugrelated Problems
dc.subjectClinical Pharmacist Interventions
dc.titleEvaluation of clinical pharmacist interventions on drugrelated problems in the gastroenterology ward
dc.typeArticle

Dosyalar

Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

Eczacılık Fakültesi Makale Koleksiyonu
TR-Dizin İndeksli Yayınlar Koleksiyonu